未登录

R

Rok Herman

university of ljubljana

H指数:10

被引数:641

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Endocrine Adaptations to Prolonged Fasting: From Physiology, Clinical Uncertainties, Translational Challenges to Healthspan Implications

内分泌对长期禁食的适应性改变：从生理学、临床不确定性、转化挑战到健康寿命影响

IF5

2025-12-170

OAAI

Efficacy of Somapacitan in Treatment-Fatigue Adult Patients With Growth Hormone Deficiency Previously Treated With Once-Daily Growth Hormone Injections: A 24-Week Randomized Active-Controlled Trial

索马帕西坦在治疗疲劳的成人生长激素缺乏患者中的疗效：一项为期24周的随机活性对照试验（该患者群体此前接受过每日一次的生长激素注射）

Endocrine Practice

IF4.6

2025-03-170

PRE

Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prader Willi syndrome - case series and literature review

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2025-01-210

OAAI

Case Report: Multiple prolactinomas in a young man with Kallmann syndrome and familial hypocalciuric hypercalcemia

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2023-10-300

OAAI

Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects

多囊卵巢综合征中的催乳素: 代谢作用和治疗前景

IF3.4

2023-10-2610

OAAI

Assessment of Eating Disorders and Eating Behavior to Improve Treatment Outcomes in Women with Polycystic Ovary Syndrome

IF3.4

2022-11-164

OAAI

Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives

IF3.9

2022-08-1620

OAAI

Clinical Applicability of Patient- and Clinician-Reported Outcome Tools in the Management of Patients With Acromegaly

ENDOCRINE PRACTICE

IF4.6

2022-07-012

PRE

Glucose transporter 4 mRNA expression in subcutaneous adipose tissue of women with PCOS remains unchanged despite metformin withdrawal: is there a cellular metabolic treatment legacy effect?

IF2.9

2021-11-103

PREAI

Genetic Variability in Antioxidative and Inflammatory Pathways Modifies the Risk for PCOS and Influences Metabolic Profile of the Syndrome

IF3.7

2020-10-2919

OAAI